Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Sep 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1613801000001113 | Dyzantil | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1613821000001118 | Dyzantil (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dyzantil | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dyzantil 300mg modified-release tablets (Aspire Pharma Ltd) | Is a | True | Dyzantil | Inferred relationship | Existential restriction modifier | |
| Dyzantil 500mg modified-release tablets (Aspire Pharma Ltd) | Is a | True | Dyzantil | Inferred relationship | Existential restriction modifier | |
| Dyzantil 200mg modified-release tablets (Aspire Pharma Ltd) | Is a | True | Dyzantil | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR